IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q3 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $18,732,000 | +97.8% | 1,125,047 | +141.2% | 0.15% | +109.9% |
Q3 2017 | $9,470,000 | -62.3% | 466,515 | -56.0% | 0.07% | -69.5% |
Q3 2016 | $25,146,000 | -42.8% | 1,061,001 | -30.4% | 0.23% | -43.6% |
Q2 2016 | $43,965,000 | +12.6% | 1,525,505 | +25.1% | 0.41% | +15.0% |
Q1 2016 | $39,035,000 | -25.2% | 1,219,074 | -0.1% | 0.36% | -35.3% |
Q4 2015 | $52,191,000 | +96.6% | 1,220,553 | +61.9% | 0.56% | +77.9% |
Q3 2015 | $26,551,000 | – | 754,089 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |